no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An international registry for emergent pathogens and pregnancy
|
Panchaud, Alice |
|
|
395 |
10235 |
p. 1483-1484 |
article |
2 |
Aspirin for secondary prevention of cardiovascular disease
|
Byrne, Robert A |
|
|
395 |
10235 |
p. 1462-1463 |
article |
3 |
Atypical presentation of COVID-19 in young infants
|
Nathan, Nadia |
|
|
395 |
10235 |
p. 1481 |
article |
4 |
Celebrating Florence Nightingale's bicentenary
|
McEnroe, Natasha |
|
|
395 |
10235 |
p. 1475-1478 |
article |
5 |
Chile plans controversial COVID-19 certificates
|
Fraser, Barbara |
|
|
395 |
10235 |
p. 1473 |
article |
6 |
COVID-19 in Brazil: “So what?”
|
The Lancet, |
|
|
395 |
10235 |
p. 1461 |
article |
7 |
Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials
|
Gaudry, Stéphane |
|
|
395 |
10235 |
p. 1506-1515 |
article |
8 |
Department of Error
|
|
|
|
395 |
10235 |
p. 1486 |
article |
9 |
Department of Error
|
|
|
|
395 |
10235 |
p. 1486 |
article |
10 |
Department of Error
|
|
|
|
395 |
10235 |
p. 1486 |
article |
11 |
Department of Error
|
|
|
|
395 |
10235 |
p. 1486 |
article |
12 |
Global call to action for inclusion of migrants and refugees in the COVID-19 response
|
Orcutt, Miriam |
|
|
395 |
10235 |
p. 1482-1483 |
article |
13 |
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
|
Chiarito, Mauro |
|
|
395 |
10235 |
p. 1487-1495 |
article |
14 |
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
|
Doyen, Denis |
|
|
395 |
10235 |
p. 1516 |
article |
15 |
New Zealand eliminates COVID-19
|
Cousins, Sophie |
|
|
395 |
10235 |
p. 1474 |
article |
16 |
Offline: Independent science advice for COVID-19—at last
|
Horton, Richard |
|
|
395 |
10235 |
p. 1472 |
article |
17 |
Psoriatic arthritis: still room for improvement
|
Hetland, Merete Lund |
|
|
395 |
10235 |
p. 1463-1465 |
article |
18 |
Reconnecting for our future: The Lancet One Health Commission
|
Amuasi, John H |
|
|
395 |
10235 |
p. 1469-1471 |
article |
19 |
SARS-CoV-2 and viral sepsis: observations and hypotheses
|
Li, Hui |
|
|
395 |
10235 |
p. 1517-1520 |
article |
20 |
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
|
McInnes, Iain B |
|
|
395 |
10235 |
p. 1496-1505 |
article |
21 |
The Global Kidney Exchange programme
|
Danovitch, Gabriel M |
|
|
395 |
10235 |
p. 1485 |
article |
22 |
The Global Kidney Exchange programme
|
López-Fraga, Marta |
|
|
395 |
10235 |
p. 1484 |
article |
23 |
The Global Kidney Exchange programme
|
Valera, Luca |
|
|
395 |
10235 |
p. 1484-1485 |
article |
24 |
The Global Kidney Exchange programme – Authors' reply
|
Singer, Peter |
|
|
395 |
10235 |
p. 1485-1486 |
article |
25 |
The key role of palliative care in response to the COVID-19 tsunami of suffering
|
Radbruch, Lukas |
|
|
395 |
10235 |
p. 1467-1469 |
article |
26 |
The worst is not, so long as we can say “this is the worst”
|
Bate, Jonathan |
|
|
395 |
10235 |
p. 1479-1480 |
article |
27 |
Timing of renal replacement therapy in acute kidney injury: case closed?
|
Nieuwenhuijs-Moeke, Gertrude J |
|
|
395 |
10235 |
p. 1465-1467 |
article |
28 |
Unfortunate distinction or corporate protectionism by design?
|
Chaufan, Claudia |
|
|
395 |
10235 |
p. 1486 |
article |
29 |
What does it mean to be made vulnerable in the era of COVID-19?
|
Ahmad, Ayesha |
|
|
395 |
10235 |
p. 1481-1482 |
article |